BridgeMD
Compares treatment options for Lateral Epicondylitis
Official title Effects of Neuromuscular Reeducation Versus Friction Massage in Lateral Epicondylitis
ClinicalTrials.gov ID: NCT07004894
What this study is testing
- What it's testing
- This study is a randomised control trial and the purpose of this study is to determine the effects of neuromuscular reeducation versus friction massage in lateral epicondylitis.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 50
You may be able to join if
- Diagnosed cases of lateral epicondylitis
- Age 25-50 years
- Both genders
- Postive tests; cozens, maudsley's, mills (at least any of 2)
You likely can't join if
- Recent elbow fractures or dislocations
- Elbow joint instability
- Active joint disease
- Open wounds around elbow joints
The study team makes the final eligibility decision.
Where it's taking place
- Islamabad, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Islamabad, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.